社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
莎士比亚的微笑
IP属地:广东
+关注
帖子 · 191
帖子 · 191
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
莎士比亚的微笑
莎士比亚的微笑
·
04-17
$小米集团-W(01810)$
30以下建仓
看
21
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
莎士比亚的微笑
莎士比亚的微笑
·
04-17
$腾讯控股(00700)$
守住500
看
103
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
莎士比亚的微笑
莎士比亚的微笑
·
04-17
$智谱(02513)$
智谱的智能体技术与长程任务处理能力,为AI在复杂场景的应用提供了技术支撑,催生了如自动订机票、数据分析、代码重构等跨应用复杂任务的落地,推动AI从“短时交互”向“长时工程”跨越。
看
328
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
莎士比亚的微笑
莎士比亚的微笑
·
04-15
$中慧生物-B(02627)$
中慧猴痘mRNA疫苗获得受理,并与重庆疾控中心等机构合作提升创新能级
看
171
回复
评论
点赞
1
编组 21备份 2
分享
举报
莎士比亚的微笑
莎士比亚的微笑
·
04-13
$阿里巴巴-W(09988)$
看明天表现
看
95
回复
评论
点赞
1
编组 21备份 2
分享
举报
莎士比亚的微笑
莎士比亚的微笑
·
04-13
$晶泰控股(02228)$
投资者需关注创新药行业政策变化、研发管线进展不及预期、以及全球资本市场对高成长科技股估值体系波动的影响
看
350
回复
评论
点赞
1
编组 21备份 2
分享
举报
莎士比亚的微笑
莎士比亚的微笑
·
04-09
$同源康医药-B(02410)$
公司于3月25日及26日连续发布公告,确认将参加2026年4月5日至10日在美国圣地亚哥举行的美国癌症研究协会(AACR)年会,并以壁报形式展示五项创新抗肿瘤药物项目的研究成果
看
220
回复
评论
点赞
1
编组 21备份 2
分享
举报
莎士比亚的微笑
莎士比亚的微笑
·
04-02
$益生股份(002458)$
养殖板块炒作时效性不会太久
看
215
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
莎士比亚的微笑
莎士比亚的微笑
·
04-02
$同源康医药-B(02410)$
公司在核心产品TY-9591的NDA进入审评阶段后,积极向国际市场展示其后续管线的研发深度和广度,以维持长期成长预期
看
415
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
莎士比亚的微笑
莎士比亚的微笑
·
03-31
$图达通(02665)$
跌久了自然就可以抄底了
看
324
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
加载更多
暂无关注
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4218427800237090","uuid":"4218427800237090","gmtCreate":1755324612195,"gmtModify":1755324688351,"name":"莎士比亚的微笑","pinyin":"ssbydwxshashibiyadeweixiao","introduction":"","introductionEn":null,"signature":"","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":0,"tweetSize":191,"questionSize":0,"limitLevel":999,"accountStatus":1,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[],"userBadgeCount":0,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"广东","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":554445654943824,"gmtCreate":1776397348420,"gmtModify":1776397350177,"author":{"id":"4218427800237090","authorId":"4218427800237090","name":"莎士比亚的微笑","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4218427800237090","authorIdStr":"4218427800237090"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/01810\">$小米集团-W(01810)$ </a> 30以下建仓","listText":"<a href=\"https://laohu8.com/S/01810\">$小米集团-W(01810)$ </a> 30以下建仓","text":"$小米集团-W(01810)$ 30以下建仓","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/554445654943824","isVote":1,"tweetType":1,"viewCount":21,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":554445536806440,"gmtCreate":1776397254416,"gmtModify":1776397256230,"author":{"id":"4218427800237090","authorId":"4218427800237090","name":"莎士比亚的微笑","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4218427800237090","authorIdStr":"4218427800237090"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/00700\">$腾讯控股(00700)$ </a> 守住500","listText":"<a href=\"https://laohu8.com/S/00700\">$腾讯控股(00700)$ </a> 守住500","text":"$腾讯控股(00700)$ 守住500","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/554445536806440","isVote":1,"tweetType":1,"viewCount":103,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":554445199792368,"gmtCreate":1776397238940,"gmtModify":1776397241081,"author":{"id":"4218427800237090","authorId":"4218427800237090","name":"莎士比亚的微笑","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4218427800237090","authorIdStr":"4218427800237090"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02513\">$智谱(02513)$ </a> 智谱的智能体技术与长程任务处理能力,为AI在复杂场景的应用提供了技术支撑,催生了如自动订机票、数据分析、代码重构等跨应用复杂任务的落地,推动AI从“短时交互”向“长时工程”跨越。","listText":"<a href=\"https://laohu8.com/S/02513\">$智谱(02513)$ </a> 智谱的智能体技术与长程任务处理能力,为AI在复杂场景的应用提供了技术支撑,催生了如自动订机票、数据分析、代码重构等跨应用复杂任务的落地,推动AI从“短时交互”向“长时工程”跨越。","text":"$智谱(02513)$ 智谱的智能体技术与长程任务处理能力,为AI在复杂场景的应用提供了技术支撑,催生了如自动订机票、数据分析、代码重构等跨应用复杂任务的落地,推动AI从“短时交互”向“长时工程”跨越。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/554445199792368","isVote":1,"tweetType":1,"viewCount":328,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":553825441290280,"gmtCreate":1776245928561,"gmtModify":1776245930643,"author":{"id":"4218427800237090","authorId":"4218427800237090","name":"莎士比亚的微笑","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4218427800237090","authorIdStr":"4218427800237090"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$ </a> 中慧猴痘mRNA疫苗获得受理,并与重庆疾控中心等机构合作提升创新能级","listText":"<a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$ </a> 中慧猴痘mRNA疫苗获得受理,并与重庆疾控中心等机构合作提升创新能级","text":"$中慧生物-B(02627)$ 中慧猴痘mRNA疫苗获得受理,并与重庆疾控中心等机构合作提升创新能级","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/553825441290280","isVote":1,"tweetType":1,"viewCount":171,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":553120660665792,"gmtCreate":1776073796175,"gmtModify":1776073798080,"author":{"id":"4218427800237090","authorId":"4218427800237090","name":"莎士比亚的微笑","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4218427800237090","authorIdStr":"4218427800237090"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/09988\">$阿里巴巴-W(09988)$ </a> 看明天表现","listText":"<a href=\"https://laohu8.com/S/09988\">$阿里巴巴-W(09988)$ </a> 看明天表现","text":"$阿里巴巴-W(09988)$ 看明天表现","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/553120660665792","isVote":1,"tweetType":1,"viewCount":95,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":553120282286336,"gmtCreate":1776073773370,"gmtModify":1776073775564,"author":{"id":"4218427800237090","authorId":"4218427800237090","name":"莎士比亚的微笑","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4218427800237090","authorIdStr":"4218427800237090"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 投资者需关注创新药行业政策变化、研发管线进展不及预期、以及全球资本市场对高成长科技股估值体系波动的影响","listText":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 投资者需关注创新药行业政策变化、研发管线进展不及预期、以及全球资本市场对高成长科技股估值体系波动的影响","text":"$晶泰控股(02228)$ 投资者需关注创新药行业政策变化、研发管线进展不及预期、以及全球资本市场对高成长科技股估值体系波动的影响","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/553120282286336","isVote":1,"tweetType":1,"viewCount":350,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":551768958645248,"gmtCreate":1775731054797,"gmtModify":1775731056893,"author":{"id":"4218427800237090","authorId":"4218427800237090","name":"莎士比亚的微笑","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4218427800237090","authorIdStr":"4218427800237090"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 公司于3月25日及26日连续发布公告,确认将参加2026年4月5日至10日在美国圣地亚哥举行的美国癌症研究协会(AACR)年会,并以壁报形式展示五项创新抗肿瘤药物项目的研究成果","listText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 公司于3月25日及26日连续发布公告,确认将参加2026年4月5日至10日在美国圣地亚哥举行的美国癌症研究协会(AACR)年会,并以壁报形式展示五项创新抗肿瘤药物项目的研究成果","text":"$同源康医药-B(02410)$ 公司于3月25日及26日连续发布公告,确认将参加2026年4月5日至10日在美国圣地亚哥举行的美国癌症研究协会(AACR)年会,并以壁报形式展示五项创新抗肿瘤药物项目的研究成果","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/551768958645248","isVote":1,"tweetType":1,"viewCount":220,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":549166983283368,"gmtCreate":1775095800824,"gmtModify":1775095803027,"author":{"id":"4218427800237090","authorId":"4218427800237090","name":"莎士比亚的微笑","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4218427800237090","authorIdStr":"4218427800237090"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/002458\">$益生股份(002458)$ </a> 养殖板块炒作时效性不会太久","listText":"<a href=\"https://laohu8.com/S/002458\">$益生股份(002458)$ </a> 养殖板块炒作时效性不会太久","text":"$益生股份(002458)$ 养殖板块炒作时效性不会太久","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/549166983283368","isVote":1,"tweetType":1,"viewCount":215,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":549166796194432,"gmtCreate":1775095753974,"gmtModify":1775095756380,"author":{"id":"4218427800237090","authorId":"4218427800237090","name":"莎士比亚的微笑","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4218427800237090","authorIdStr":"4218427800237090"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 公司在核心产品TY-9591的NDA进入审评阶段后,积极向国际市场展示其后续管线的研发深度和广度,以维持长期成长预期","listText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 公司在核心产品TY-9591的NDA进入审评阶段后,积极向国际市场展示其后续管线的研发深度和广度,以维持长期成长预期","text":"$同源康医药-B(02410)$ 公司在核心产品TY-9591的NDA进入审评阶段后,积极向国际市场展示其后续管线的研发深度和广度,以维持长期成长预期","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/549166796194432","isVote":1,"tweetType":1,"viewCount":415,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":548548469457760,"gmtCreate":1774946450351,"gmtModify":1774946452362,"author":{"id":"4218427800237090","authorId":"4218427800237090","name":"莎士比亚的微笑","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4218427800237090","authorIdStr":"4218427800237090"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02665\">$图达通(02665)$ </a> 跌久了自然就可以抄底了","listText":"<a href=\"https://laohu8.com/S/02665\">$图达通(02665)$ </a> 跌久了自然就可以抄底了","text":"$图达通(02665)$ 跌久了自然就可以抄底了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/548548469457760","isVote":1,"tweetType":1,"viewCount":324,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"following","isTTM":false}